Barclays’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $270K | Buy |
18,011
+3,782
| +27% | +$56.7K | ﹤0.01% | 3360 |
|
|
2025
Q1 | $167K | Sell |
14,229
-3,304
| -19% | -$38.8K | ﹤0.01% | 3432 |
|
|
2024
Q4 | $401K | Buy |
17,533
+2,674
| +18% | +$61.2K | ﹤0.01% | 3183 |
|
|
2024
Q3 | $623K | Buy |
14,859
+11,316
| +319% | +$474K | ﹤0.01% | 2868 |
|
|
2024
Q2 | $129K | Sell |
3,543
-8,457
| -70% | -$308K | ﹤0.01% | 3258 |
|
|
2024
Q1 | $611K | Buy |
+12,000
| New | +$611K | ﹤0.01% | 2720 |
|
|
2023
Q3 | – | Sell |
-8
| Closed | – | – | 4340 |
|
|
2023
Q2 | $0 | Sell |
8
-257
| -97% | – | ﹤0.01% | 4352 |
|
|
2023
Q1 | $4K | Sell |
265
-22,348
| -99% | -$337K | ﹤0.01% | 4179 |
|
|
2022
Q4 | $230K | Hold |
22,613
| – | – | ﹤0.01% | 3022 |
|
|
2022
Q3 | $289K | Hold |
22,613
| – | – | ﹤0.01% | 2880 |
|
|
2022
Q2 | $466K | Sell |
22,613
-285
| -1% | -$5.87K | ﹤0.01% | 2626 |
|
|
2022
Q1 | $861K | Buy |
+22,898
| New | +$861K | ﹤0.01% | 2430 |
|
|
2019
Q1 | – | Sell |
-480
| Closed | -$21K | – | 4351 |
|
|
2018
Q4 | $21K | Sell |
480
-400
| -45% | -$17.5K | ﹤0.01% | 3371 |
|
|
2018
Q3 | $52K | Buy |
+880
| New | +$52K | ﹤0.01% | 3728 |
|
|
2018
Q2 | – | Sell |
-3
| Closed | -$1K | – | 4306 |
|
|
2018
Q1 | $1K | Hold |
3
| – | – | ﹤0.01% | 4134 |
|
|
2017
Q4 | $1K | Buy |
+3
| New | +$1K | ﹤0.01% | 4015 |
|
|
2017
Q3 | – | Sell |
-10
| Closed | -$3K | – | 4086 |
|
|
2017
Q2 | $3K | Buy |
10
+1
| +11% | +$300 | ﹤0.01% | 3630 |
|
|
2017
Q1 | $3K | Sell |
9
-42
| -82% | -$14K | ﹤0.01% | 3718 |
|
|
2016
Q4 | $16K | Buy |
51
+18
| +55% | +$5.65K | ﹤0.01% | 3155 |
|
|
2016
Q3 | $9K | Buy |
33
+22
| +200% | +$6K | ﹤0.01% | 3290 |
|
|
2016
Q2 | $1K | Buy |
11
+5
| +83% | +$455 | ﹤0.01% | 3436 |
|
|
2016
Q1 | $1K | Sell |
6
-8
| -57% | -$1.33K | ﹤0.01% | 3312 |
|
|
2015
Q4 | $3K | Buy |
+14
| New | +$3K | ﹤0.01% | 2983 |
|